Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Post

Showing results (171-180 of 215) with videos related to

Pageof 22
Sort By:
Physiological Reports|December 29, 2018
Recombinant human erythropoietin does not affect several microvascular parameters in well-trained cyclistsWillem A J Birkhoff, Jules A A C Heuberger, Titiaan E Post, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 24, 2026
Judicious elevation of ambient carbon dioxide during hypobaric hypoxia to improve oxygenation in airline passengers - a randomized feasibility studyTitiaan E Post, Riccardo De Gioannis, Daniel Rooney, et al.
Journal of Pain and Symptom Management|February 2, 2024
Dyspnea-Related Dimensions And Self-Efficacy: Associations With Well-Being in Advanced Lung CancerStephen B Lo, Anna L Ruprecht, Kathryn E Post, et al.
Proteins|October 1, 1986
Isolation and characterization of native human renin derived from Chinese hamster ovary cellsR A Poorman, D P Palermo, L E Post, et al.
Blood|December 9, 2000
Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical responseJ Yang, Q Tao, I W Flinn, et al.
Cancer Research|July 20, 2007
Targeted cancer gene therapy using a hypoxia inducible factor dependent oncolytic adenovirus armed with interleukin-4Dawn E Post, Eric M Sandberg, Michele M Kyle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2013
BMN 673, a novel and highly potent PARP1/2 inhibitor for the treatment of human cancers with DNA repair deficiencyYuqiao Shen, Farah L Rehman, Ying Feng, et al.
Msphere|February 8, 2017
TgPRELID, a Mitochondrial Protein Linked to Multidrug Resistance in the Parasite <i>Toxoplasma gondii</i>Victoria Jeffers, Edwin T Kamau, Ananth R Srinivasan, et al.
Journal of Pain and Symptom Management|October 10, 2023
Managing Symptom Distress: Key Factors for Patients on Adjuvant Endocrine Therapy for Breast CancerKathryn E Post, Zeba Ahmad, Greta Jankauskaite, et al.
Breast Cancer Research and Treatment|November 21, 2025
Improving adjuvant endocrine therapy initiation among patients with breast cancer: a nurse-led, culturally sensitive pilot studyKathryn E Post, Laura Dunderdale, Shibani Datta, et al.
Pageof 22

Showing results (171-180 of 215) with videos related to

Sort By:
Pageof 22
Physiological Reports|December 29, 2018
Recombinant human erythropoietin does not affect several microvascular parameters in well-trained cyclistsWillem A J Birkhoff, Jules A A C Heuberger, Titiaan E Post, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 24, 2026
Judicious elevation of ambient carbon dioxide during hypobaric hypoxia to improve oxygenation in airline passengers - a randomized feasibility studyTitiaan E Post, Riccardo De Gioannis, Daniel Rooney, et al.
Journal of Pain and Symptom Management|February 2, 2024
Dyspnea-Related Dimensions And Self-Efficacy: Associations With Well-Being in Advanced Lung CancerStephen B Lo, Anna L Ruprecht, Kathryn E Post, et al.
Proteins|October 1, 1986
Isolation and characterization of native human renin derived from Chinese hamster ovary cellsR A Poorman, D P Palermo, L E Post, et al.
Blood|December 9, 2000
Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical responseJ Yang, Q Tao, I W Flinn, et al.
Cancer Research|July 20, 2007
Targeted cancer gene therapy using a hypoxia inducible factor dependent oncolytic adenovirus armed with interleukin-4Dawn E Post, Eric M Sandberg, Michele M Kyle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2013
BMN 673, a novel and highly potent PARP1/2 inhibitor for the treatment of human cancers with DNA repair deficiencyYuqiao Shen, Farah L Rehman, Ying Feng, et al.
Msphere|February 8, 2017
TgPRELID, a Mitochondrial Protein Linked to Multidrug Resistance in the Parasite <i>Toxoplasma gondii</i>Victoria Jeffers, Edwin T Kamau, Ananth R Srinivasan, et al.
Journal of Pain and Symptom Management|October 10, 2023
Managing Symptom Distress: Key Factors for Patients on Adjuvant Endocrine Therapy for Breast CancerKathryn E Post, Zeba Ahmad, Greta Jankauskaite, et al.
Breast Cancer Research and Treatment|November 21, 2025
Improving adjuvant endocrine therapy initiation among patients with breast cancer: a nurse-led, culturally sensitive pilot studyKathryn E Post, Laura Dunderdale, Shibani Datta, et al.
Pageof 22